{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T14:07:23Z","timestamp":1784383643051,"version":"3.55.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Otolaryngologic Clinics of North America"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.otc.2022.09.012","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T03:12:38Z","timestamp":1666062758000},"page":"157-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Unified Airway Disease"],"prefix":"10.1016","volume":"56","author":[{"given":"Eamon","family":"Shamil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.otc.2022.09.012_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-66479-8","article-title":"Bidirectional association between asthma and chronic rhinosinusitis: Two longitudinal follow-up studies using a national sample cohort","volume":"10","author":"Ryu","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.otc.2022.09.012_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1398-9995.2011.02709.x","article-title":"Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe","volume":"67","author":"Jarvis","year":"2012","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.otc.2022.09.012_bib3","doi-asserted-by":"crossref","DOI":"10.1186\/s12948-018-0103-x","article-title":"Comorbidities are associated with different features of severe asthma","volume":"16","author":"Novelli","year":"2018","journal-title":"Clin Mol Allergy"},{"issue":"4","key":"10.1016\/j.otc.2022.09.012_bib4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4193\/Rhino09.095","article-title":"Comparative clinical and airway inflammatory features of asthmatics with or without polyps","volume":"48","author":"Bilodeau","year":"2010","journal-title":"Rhinology"},{"issue":"9","key":"10.1016\/j.otc.2022.09.012_bib5","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/all.12447","article-title":"The relation of airway obstruction to asthma, chronic rhinosinusitis and age: results from a population survey of adults","volume":"69","author":"Obaseki","year":"2014","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.otc.2022.09.012_bib6","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/j.1398-9995.2006.01225.x","article-title":"Differentiation of chronic sinus diseases by measurement of inflammatory mediators","volume":"61","author":"Van Zele","year":"2006","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.otc.2022.09.012_bib7","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.jaip.2020.03.007","article-title":"Endotypes of chronic rhinosinusitis with nasal polyps: pathology and possible therapeutic implications","volume":"8","author":"Bachert","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.otc.2022.09.012_bib8","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaci.2008.07.008","article-title":"Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease","volume":"122","author":"Zhang","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.otc.2022.09.012_bib9","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/cea.12378","article-title":"Th17 response and its regulation in inflammatory upper airway diseases","volume":"45","author":"Liu","year":"2015","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.otc.2022.09.012_bib10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/1744666X.2016.1220833","article-title":"Chronic rhinosinusitis: the rationale for current treatments","volume":"13","author":"Ghogomu","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"issue":"8","key":"10.1016\/j.otc.2022.09.012_bib11","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1016\/j.jaip.2019.05.009","article-title":"Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis","volume":"7","author":"Stevens","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.otc.2022.09.012_bib12","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","article-title":"Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers","volume":"137","author":"Tomassen","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.otc.2022.09.012_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jaci.2020.04.040","article-title":"Type 2 inflammation in chronic rhinosinusitis without nasal polyps: Another relevant endotype","volume":"146","author":"Delemarre","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.otc.2022.09.012_bib14","unstructured":"Fokkens W.J., Lund V.J., Hopkins C., et al., European Position Paper on Rhinosinusitis and Nasal Polyps 2020, Rhinology, 58 (Suppl S29), 2020, 1-464."},{"issue":"4","key":"10.1016\/j.otc.2022.09.012_bib15","doi-asserted-by":"crossref","DOI":"10.1007\/s11882-018-0776-8","article-title":"Precision medicine in chronic rhinosinusitis with nasal polyps","volume":"18","author":"Avdeeva","year":"2018","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"10.1016\/j.otc.2022.09.012_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMcp1800215","article-title":"Chronic rhinosinusitis with nasal polyps","volume":"381","author":"Hopkins","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.otc.2022.09.012_bib17","article-title":"Saline irrigation for chronic rhinosinusitis","volume":"2016","author":"Chong","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.otc.2022.09.012_bib18","article-title":"Different types of intranasal steroids for chronic rhinosinusitis","volume":"2016","author":"Chong","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.otc.2022.09.012_bib19","article-title":"Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis","volume":"2016","author":"Chong","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.otc.2022.09.012_bib20","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1001\/jamaoto.2016.1110","article-title":"Utilization patterns of topical intranasal steroid therapy for chronic rhinosinusitis: a canadian population-based analysis","volume":"142","author":"Rudmik","year":"2016","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.otc.2022.09.012_bib21","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jaci.2014.06.038","article-title":"Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma","volume":"135","author":"Dixon","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.otc.2022.09.012_bib22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0145561321998521","article-title":"Use of off-label nasal steroid irrigations in long-term management of chronic rhinosinusitis","volume":"100","author":"Jiramongkolchai","year":"2021","journal-title":"Ear Nose Throat J"},{"issue":"4","key":"10.1016\/j.otc.2022.09.012_bib23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/alr.22093","article-title":"Corticosteroid nasal irrigations are more effective than simple sprays in a randomized double-blinded placebo-controlled trial for chronic rhinosinusitis after sinus surgery","volume":"8","author":"Harvey","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.otc.2022.09.012_bib24","first-page":"CD006549","article-title":"Topical steroids for nasal polyps","volume":"12","author":"Kalish","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.otc.2022.09.012_bib25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jamaoto.2018.0667","article-title":"Effect of budesonide added to large-volume, low-pressure saline sinus irrigation for chronic rhinosinusitis: a randomized clinical trial","volume":"144","author":"Tait","year":"2018","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.otc.2022.09.012_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/alr.22894","article-title":"The possibility of short-term hypothalamic-pituitary-adrenal axis suppression with high-volume, high-dose nasal mometasone irrigation in postsurgical patients with chronic rhinosinusitis","volume":"12","author":"Brown","year":"2022","journal-title":"Int Forum Allergy Rhinol"},{"issue":"3","key":"10.1016\/j.otc.2022.09.012_bib27","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/alr.21700","article-title":"Safety of long-term high-volume sinonasal budesonide irrigations for chronic rhinosinusitis","volume":"6","author":"Smith","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"issue":"1","key":"10.1016\/j.otc.2022.09.012_bib28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/1945892418810281","article-title":"NAVIGATE I: randomized, placebo-controlled, double-blind trial of the exhalation delivery system with fluticasone for chronic rhinosinusitis with nasal polyps","volume":"33","author":"Sindwani","year":"2019","journal-title":"Am J Rhinol Allergy"},{"issue":"1","key":"10.1016\/j.otc.2022.09.012_bib29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaci.2018.06.010","article-title":"NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis","volume":"143","author":"Leopold","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.otc.2022.09.012_bib30","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/alr.22443","article-title":"Efficacy of steroid eluting stents in management of chronic rhinosinusitis following endoscopic sinus surgery: updated meta-analysis","volume":"9","author":"Goshtasbi","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10.1016\/j.otc.2022.09.012_bib31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/alr.22084","article-title":"A\u00a0phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps","volume":"8","author":"Kern","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"issue":"6","key":"10.1016\/j.otc.2022.09.012_bib32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/alr.21741","article-title":"RESOLVE: bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis after sinus surgery: 6-month outcomes from a randomized, controlled, blinded study","volume":"6","author":"Forwith","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"issue":"11","key":"10.1016\/j.otc.2022.09.012_bib33","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/alr.21426","article-title":"RESOLVE: a randomized, controlled, blinded study of bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis","volume":"4","author":"Han","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"issue":"S1","key":"10.1016\/j.otc.2022.09.012_bib34","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1002\/alr.22344","article-title":"Topical therapies for management of chronic rhinosinusitis: steroid implants","volume":"9","author":"Han","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10.1016\/j.otc.2022.09.012_bib35","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/alr.22288","article-title":"Phase 1 clinical study to assess the safety of a novel drug delivery system providing long-term topical steroid therapy for chronic rhinosinusitis","volume":"9","author":"Douglas","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"issue":"6","key":"10.1016\/j.otc.2022.09.012_bib36","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.jaci.2012.01.079","article-title":"Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy","volume":"129","author":"Wen","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.otc.2022.09.012_bib37","article-title":"Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis","volume":"2016","author":"Head","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.otc.2022.09.012_bib38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2017.04.009","article-title":"Oral corticosteroid exposure and adverse effects in asthmatic patients","volume":"141","author":"Sullivan","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.otc.2022.09.012_bib39","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1378\/chest.120.5.1468","article-title":"Effects of inhaled corticosteroid and short courses of oral corticosteroids on bone mineral density in asthmatic patients : a 4-year longitudinal study","volume":"120","author":"Matsumoto","year":"2001","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.otc.2022.09.012_bib40","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"3","key":"10.1016\/j.otc.2022.09.012_bib41","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/lary.28843","article-title":"Should oral corticosteroids be used in medical therapy for chronic rhinosinusitis? A risk analysis","volume":"131","author":"Leung","year":"2021","journal-title":"Laryngoscope"},{"issue":"4","key":"10.1016\/j.otc.2022.09.012_bib42","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2500\/ajra.2009.23.3334","article-title":"Efficacy of targeted medical therapy in chronic rhinosinusitis, and predictors of failure","volume":"23","author":"Lal","year":"2009","journal-title":"Am J Rhinol Allergy"},{"issue":"7","key":"10.1016\/j.otc.2022.09.012_bib43","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/alr.21315","article-title":"The fate of chronic rhinosinusitis sufferers after maximal medical therapy","volume":"4","author":"Baguley","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10.1016\/j.otc.2022.09.012_bib44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/alr.21101","article-title":"Prevalence and abundance of Staphylococcus aureus in the middle meatus of patients with chronic rhinosinusitis, nasal polyps, and asthma","volume":"3","author":"Ramakrishnan","year":"2013","journal-title":"Int Forum Allergy Rhinol"},{"issue":"2","key":"10.1016\/j.otc.2022.09.012_bib45","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaip.2018.08.020","article-title":"Staphylococcus aureus nasal colonization and asthma in adults: systematic review and meta-analysis","volume":"7","author":"Kim","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.otc.2022.09.012_bib46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4193\/Rhino15.291","article-title":"Prospective open-label evaluation of long-term low-dose doxycycline for difficult-to-treat chronic rhinosinusitis with nasal polyps","volume":"55","author":"Pinto Bezerra Soter","year":"2017","journal-title":"Rhinology"},{"issue":"5","key":"10.1016\/j.otc.2022.09.012_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2010.02.020","article-title":"Oral steroids and doxycycline: two different approaches to treat nasal polyps","volume":"125","author":"Van Zele","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.otc.2022.09.012_bib48","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/alr.21318","article-title":"Efficacy of long-term low-dose macrolide therapy in preventing early recurrence of nasal polyps after endoscopic sinus surgery","volume":"4","author":"Varvyanskaya","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"issue":"2","key":"10.1016\/j.otc.2022.09.012_bib49","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/01.mlg.0000191560.53555.08","article-title":"A\u00a0double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis","volume":"116","author":"Wallwork","year":"2006","journal-title":"Laryngoscope"},{"issue":"4","key":"10.1016\/j.otc.2022.09.012_bib51","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2213-2600(21)00457-4","article-title":"Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial","volume":"10","author":"Lourijsen","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.otc.2022.09.012_bib52","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaip.2020.09.063","article-title":"Chronic rhinosinusitis with nasal polyps and asthma","volume":"9","author":"Laidlaw","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.otc.2022.09.012_bib56","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/alr.22780","article-title":"Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps","volume":"11","author":"Hopkins","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"issue":"8","key":"10.1016\/j.otc.2022.09.012_bib57","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/alr.22774","article-title":"Benefits of biologic therapy administered for asthma on co-existent chronic rhinosinusitis: a real-world study","volume":"11","author":"Bajpai","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"issue":"3","key":"10.1016\/j.otc.2022.09.012_bib58","article-title":"Biologics for chronic rhinosinusitis","volume":"2021","author":"Chong","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.otc.2022.09.012_bib59","first-page":"A4845","article-title":"Dupilumab improved health-related quality of life in asthma patients with comorbid chronic rhinosinusitis: QUEST study","author":"Hopkins","year":"2022","journal-title":"Am Thorac Soc Int"},{"key":"10.1016\/j.otc.2022.09.012_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2022.04.007","article-title":"Rapid and sustained effect of dupilumab on clinical and mechanistic outcomes in aspirin-exacerbated respiratory disease","author":"Buchheit","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.otc.2022.09.012_bib61","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/all.15134","article-title":"Real-life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps","volume":"77","author":"Lans van der","year":"2022","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.otc.2022.09.012_bib62","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Han","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.otc.2022.09.012_bib63","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jaip.2018.08.021","article-title":"Effects of reslizumab on asthma outcomes in a subgroup of eosinophilic asthma patients with self-reported chronic rhinosinusitis with nasal polyps","volume":"7","author":"Weinstein","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.otc.2022.09.012_bib64","doi-asserted-by":"crossref","first-page":"AB86","DOI":"10.1016\/j.jaci.2015.12.408","article-title":"Efficacy of reslizumab with asthma, chronic sinusitis with nasal polyps and elevated blood eosinophils","volume":"137","author":"Hayashi","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.otc.2022.09.012_bib65","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jaci.2021.08.030","article-title":"Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial","volume":"149","author":"Bachert","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.otc.2022.09.012_bib66","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","article-title":"Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials","volume":"146","author":"Gevaert","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.otc.2022.09.012_bib67","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaci.2020.11.013","article-title":"EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management","volume":"147","author":"Bachert","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.otc.2022.09.012_bib68","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000519228","article-title":"Which is the best biologic for nasal polyps: dupilumab, omalizumab, or mepolizumab? A network meta-analysis","volume":"183","author":"Wu","year":"2022","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.otc.2022.09.012_bib69","doi-asserted-by":"crossref","DOI":"10.1111\/cea.14152","article-title":"Mepolizumab decreases tissue eosinophils while increasing type-2 cytokines in eosinophilic chronic rhinosinusitis","author":"Walter","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.otc.2022.09.012_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2022.02.017","article-title":"Biologicals and endoscopic sinus surgery for severe uncontrolled chronic rhinosinusitis with nasal polyps: an economic perspective","author":"van der Lans","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"10209","key":"10.1016\/j.otc.2022.09.012_bib71","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.otc.2022.09.012_bib72","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.1002\/lary.28648","article-title":"Cost utility analysis of dupilumab versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps","volume":"131","author":"Scangas","year":"2021","journal-title":"Laryngoscope"},{"issue":"12","key":"10.1016\/j.otc.2022.09.012_bib73","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/alr.22865","article-title":"Cost-effectiveness analysis comparing dupilumab and aspirin desensitization therapy for chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease","volume":"11","author":"Yong","year":"2021","journal-title":"Int Forum Allergy Rhinol"}],"container-title":["Otolaryngologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666522001347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666522001347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T14:54:41Z","timestamp":1758466481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0030666522001347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0030666522001347"],"URL":"https:\/\/doi.org\/10.1016\/j.otc.2022.09.012","relation":{},"ISSN":["0030-6665"],"issn-type":[{"value":"0030-6665","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unified Airway Disease","name":"articletitle","label":"Article Title"},{"value":"Otolaryngologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otc.2022.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}